참고문헌
- Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis. 2006 ; 17(12) : 1726-33. https://doi.org/10.1007/s00198-006-0172-4
- Silverman SL, Lane NE. Glucocorticoid-induced osteoporosis. Curr Osteoporos Rep. 2009 ; 7(1) : 23-6. https://doi.org/10.1007/s11914-009-0005-4
- Nishikawa M, Akatsu T, Katayama Y, Yasutomo Y, Kado S, Kugal N, Yamamoto M, Nagata N. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone. 1996 ; 18 : 9-14. https://doi.org/10.1016/8756-3282(95)00426-2
- Abrahamsen B. Bisphosphonate adverse effects, lessons from large databases. Curr Opin Rheumatol. 2010 ; 22(4) : 404-9. https://doi.org/10.1097/BOR.0b013e32833ad677
- Kim JY, Jung JH, Lee MS, Lee CH, Kim YK, Jeon BH, Kwak HB, Kim JY, Choi MK, Kim JJ, Oh JM. Effect of Saururus Chinensis in RANKL-induced Osteoclast Differentiation. Kor J Ori Med Physiol Pathol. 2012 ; 26(6) : 869-73.
- Kim JY, Kim YK, Choi MK, Oh JM, Kwak HB, Kim JJ. Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation. J Bone Metab. 2012 ; 19(2) : 121-7. https://doi.org/10.11005/jbm.2012.19.2.121
- Kim KM. Effects of papaya water extract on RANKL-induced osteoclast Differentiation. Faculty of Medical Science, Wonkwang University Graduate School. 2009.
- Kim JH, Ki JY, Ann JY, Park HJ, Kim HJ, Kwak HB, Oh JM, Kim YK. Inhibitory Effects of Achyranthis Bidentatae Radix on Osteoclast Differentiation and Bone Resorption. Kor J Herbology. 2010 ; 25(1) : 65-74.
- Goltzman D. Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov. 2002 ; (10) : 784-96.
- Ikeda F, Nishimura R, Matsubara T, Hata K, Reddy SV, Yoneda T. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol. 2006 ; 177(4) : 2384-90. https://doi.org/10.4049/jimmunol.177.4.2384
- Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999 ; 20 : 345-57. https://doi.org/10.1210/edrv.20.3.0367
- Hofbauer LC, Dunstan CR, Lacey, DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000 ; 15 : 2-12. https://doi.org/10.1359/jbmr.2000.15.1.2
- Lee ZH, Kim HH. Signal Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003 ; 305 : 211-4. https://doi.org/10.1016/S0006-291X(03)00695-8
- Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007 ; 7 : 292-304. https://doi.org/10.1038/nri2062
- Matsuo K, Galson DL, Zhao C, et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004 ; 279 : 26475-80. https://doi.org/10.1074/jbc.M313973200
- Jung HS, Song BY, Lee CH, Yook TH. Effects of Cinnamomi Cortex and Aconitum Carmichaeli's Pharmacopuncture and Oral Administration on Blood Sugar in Type II Diabetic Mice. The Acupuncture. 2010 ; 27(5) : 1-12.
- Ameri A. The effects of Aconitum alkaloids on the central nervous system. Prog Neurobiol. 1998 ; 56 : 211-35. https://doi.org/10.1016/S0301-0082(98)00037-9
-
Mitamura M, Horie S, Sakaguchi M, Someya A, Tsuchiya S. Van de Voorde J, Murayama T, Watanabe K. Mesaconitine-induced relaxation in rat aorta: involvement of
$Ca^{2+}$ influx and nitric-oxide synthase in the endothelium. Eur J Pharmacol. 2003 ; 436 : 217-25. - Zhu YP. Chinese Materia Medica Chemistry, Pharmacology and Applications. Amsterdam : Harwood Academic Publishers. 1998 : 353-6.
- Kurokawa M. Imakita M, Kumeda CA, Shiraki K. Cascade of fever production in mice infected with influenza virus. J Med Virol. 1996 ; 50 : 152-8. https://doi.org/10.1002/(SICI)1096-9071(199610)50:2<152::AID-JMV8>3.0.CO;2-9
- McBride TJ, Panrucker S, Clothier JC. Hip fractures: public perceptions. Ann R Coll Surg Engl. 2011 ; 93 : 67-70. https://doi.org/10.1308/003588411X12851639107034
- Looker AC, Johnston CC Jr, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Lindsay RL. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res. 1995; 10 : 796-802.
- Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study. Calcif Tissue Int. 2010 ; 86(5) :335-42. https://doi.org/10.1007/s00223-010-9349-0
- Watts NB, Diab DL. Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab. 2010; 95(4) : 1555-1565. https://doi.org/10.1210/jc.2009-1947
- The Younglimsa Editorial Office. Oriental Medicine Unabridged Terminology Dictionary. Seoul : Younglimsa. 2007 : 99,777.
- Seo BI, Lee JH, Choi HY, Kwon DY, Bu YM. Herbal Medicine Herbalogy. Seoul : Younglimsa. 2004 : 440-1.
- Ikeda F, Nishimura R, Matsubara T, Hata K, Reddy SV, Yoneda T. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol. 2006 ; 177(4) : 2384-90. https://doi.org/10.4049/jimmunol.177.4.2384
- Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999 ; 13(18) : 2412-24. https://doi.org/10.1101/gad.13.18.2412
- Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappa B and c-Jun N-terminal kinase. J Biol Chem. 1998 ; 273 : 20551-5. https://doi.org/10.1074/jbc.273.32.20551
-
Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y. The TRAF family of signal transducers mediates NF-
${\kappa}B$ activation by the TRANCE receptor. J Biol Chem. 1998 ; 273(43) : 28355-9. https://doi.org/10.1074/jbc.273.43.28355 - Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002 ; 3: 889-901. https://doi.org/10.1016/S1534-5807(02)00369-6
- Partington GA, Fuller K, Chambers TJ, Pondel M. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation. Bone. 2004 ; 34(2) : 237-45. https://doi.org/10.1016/j.bone.2003.11.010
- Shimizu H, Nakagami H, Tsukamoto I, Morita S, Kunugiza Y, Tomita T, Yoshikawa H, Kaneda Y, Ogihara T, Morishita R. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Gene Ther. 2006 ; 13(12) : 933-41. https://doi.org/10.1038/sj.gt.3302711
- Choe CM, Lee SJ, Park KH, Kim SB, Cho HB. Effects of Woogwiyeum on the Ovariectomized Rat Model of Postmenopausal Osteoporosis. J Oriental Obstet Gynecol. 2006 ; 19(4): 77-92.
- Jang DS, Kim KH. The Effects of Kamipalmijiwhangtang and Kamigangwhalsokdantang on Osteoporosis in Ovariectomized Rats. Korean Soc Oriental Prev Med. 1999 ; 3(1) : 1-33.